N-[(2S,3R,4S,6R)-2-[[(1S,3R,4R,8S,9R,12R,13S,14S,15R,16R)-5-[4-[3-cyclopentyloxy-N-[(3,5-dichloro-4-pyridinyl)methyl]-4-methoxyanilino]butyl]-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-9-iodo-3,8,12,14,16-pentamethyl-2,6,11-trioxo-7,10,17-trioxa-5-azatricyclo[14.2.1.04,8]nonadecan-15-yl]oxy]-3-hydroxy-6-methyloxan-4-yl]-N-methylmorpholine-4-carboxamide

C62H90Cl2IN5O17 — CID 89117843

IUPACN-[(2S,3R,4S,6R)-2-[[(1S,3R,4R,8S,9R,12R,13S,14S,15R,16R)-5-[4-[3-cyclopentyloxy-N-[(3,5-dichloro-4-pyridinyl)methyl]-4-methoxyanilino]butyl]-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-9-iodo-3,8,12,14,16-pentamethyl-2,6,11-trioxo-7,10,17-trioxa-5-azatricyclo[14.2.1.04,8]nonadecan-15-yl]oxy]-3-hydroxy-6-methyloxan-4-yl]-N-methylmorpholine-4-carboxamide
SMILESCOc1ccc(N(CCCCN2C(=O)O[C@]3(C)[C@@H](I)OC(=O)[C@H](C)[C@@H](O[C@H]4C[C@@](C)(OC)[C@@H](O)[C@H](C)O4)[C@H](C)[C@@H](O[C@@H]4O[C@H](C)C[C@H](N(C)C(=O)N5CCOCC5)[C@H]4O)[C@@]4(C)C[C@@H](CO4)C(=O)[C@H](C)[C@@H]23)Cc2c(Cl)cncc2Cl)cc1OC1CCCC1
InChIInChI=1S/C62H90Cl2IN5O17/c1-34-26-45(67(9)58(75)68-22-24-79-25-23-68)50(72)56(81-34)85-54-36(3)51(84-48-29-60(6,78-11)53(73)38(5)82-48)37(4)55(74)86-57(65)62(8)52(35(2)49(71)39-28-61(54,7)80-33-39)70(59(76)87-62)21-15-14-20-69(32-42-43(63)30-66-31-44(42)64)40-18-19-46(77-10)47(27-40)83-41-16-12-13-17-41/h18-19,27,30-31,34-39,41,45,48,50-54,56-57,72-73H,12-17,20-26,28-29,32-33H2,1-11H3/t34-,35+,36+,37-,38+,39+,45+,48+,50-,51+,52-,53+,54-,56+,57+,60-,61-,62+/m1/s1
InChIKeyUIPKAULEVIFHCO-HQLLEASNSA-N
MW1375.23 g/mol
LogP8.59
Rot. Bonds17

About N-[(2S,3R,4S,6R)-2-[[(1S,3R,4R,8S,9R,12R,13S,14S,15R,16R)-5-[4-[3-cyclopentyloxy-N-[(3,5-dichloro-4-pyridinyl)methyl]-4-methoxyanilino]butyl]-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-9-iodo-3,8,12,14,16-pentamethyl-2,6,11-trioxo-7,10,17-trioxa-5-azatricyclo[14.2.1.04,8]nonadecan-15-yl]oxy]-3-hydroxy-6-methyloxan-4-yl]-N-methylmorpholine-4-carboxamide

N-[(2S,3R,4S,6R)-2-[[(1S,3R,4R,8S,9R,12R,13S,14S,15R,16R)-5-[4-[3-cyclopentyloxy-N-[(3,5-dichloro-4-pyridinyl)methyl]-4-methoxyanilino]butyl]-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-9-iodo-3,8,12,14,16-pentamethyl-2,6,11-trioxo-7,10,17-trioxa-5-azatricyclo[14.2.1.04,8]nonadecan-15-yl]oxy]-3-hydroxy-6-methyloxan-4-yl]-N-methylmorpholine-4-carboxamide (PubChem CID 89117843) has the molecular formula C62H90Cl2IN5O17 and a molecular weight of 1375.23 g/mol. Its IUPAC name is N-[(2S,3R,4S,6R)-2-[[(1S,3R,4R,8S,9R,12R,13S,14S,15R,16R)-5-[4-[3-cyclopentyloxy-N-[(3,5-dichloro-4-pyridinyl)methyl]-4-methoxyanilino]butyl]-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-9-iodo-3,8,12,14,16-pentamethyl-2,6,11-trioxo-7,10,17-trioxa-5-azatricyclo[14.2.1.04,8]nonadecan-15-yl]oxy]-3-hydroxy-6-methyloxan-4-yl]-N-methylmorpholine-4-carboxamide.

Molecular Properties

Compound NameN-[(2S,3R,4S,6R)-2-[[(1S,3R,4R,8S,9R,12R,13S,14S,15R,16R)-5-[4-[3-cyclopentyloxy-N-[(3,5-dichloro-4-pyridinyl)methyl]-4-methoxyanilino]butyl]-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-9-iodo-3,8,12,14,16-pentamethyl-2,6,11-trioxo-7,10,17-trioxa-5-azatricyclo[14.2.1.04,8]nonadecan-15-yl]oxy]-3-hydroxy-6-methyloxan-4-yl]-N-methylmorpholine-4-carboxamide
PubChem CID89117843
Molecular FormulaC62H90Cl2IN5O17
Molecular Weight1375.23 g/mol
Exact Mass1373.48
IUPAC NameN-[(2S,3R,4S,6R)-2-[[(1S,3R,4R,8S,9R,12R,13S,14S,15R,16R)-5-[4-[3-cyclopentyloxy-N-[(3,5-dichloro-4-pyridinyl)methyl]-4-methoxyanilino]butyl]-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-9-iodo-3,8,12,14,16-pentamethyl-2,6,11-trioxo-7,10,17-trioxa-5-azatricyclo[14.2.1.04,8]nonadecan-15-yl]oxy]-3-hydroxy-6-methyloxan-4-yl]-N-methylmorpholine-4-carboxamide
SMILESCOc1ccc(N(CCCCN2C(=O)O[C@]3(C)[C@@H](I)OC(=O)[C@H](C)[C@@H](O[C@H]4C[C@@](C)(OC)[C@@H](O)[C@H](C)O4)[C@H](C)[C@@H](O[C@@H]4O[C@H](C)C[C@H](N(C)C(=O)N5CCOCC5)[C@H]4O)[C@@]4(C)C[C@@H](CO4)C(=O)[C@H](C)[C@@H]23)Cc2c(Cl)cncc2Cl)cc1OC1CCCC1
InChIInChI=1S/C62H90Cl2IN5O17/c1-34-26-45(67(9)58(75)68-22-24-79-25-23-68)50(72)56(81-34)85-54-36(3)51(84-48-29-60(6,78-11)53(73)38(5)82-48)37(4)55(74)86-57(65)62(8)52(35(2)49(71)39-28-61(54,7)80-33-39)70(59(76)87-62)21-15-14-20-69(32-42-43(63)30-66-31-44(42)64)40-18-19-46(77-10)47(27-40)83-41-16-12-13-17-41/h18-19,27,30-31,34-39,41,45,48,50-54,56-57,72-73H,12-17,20-26,28-29,32-33H2,1-11H3/t34-,35+,36+,37-,38+,39+,45+,48+,50-,51+,52-,53+,54-,56+,57+,60-,61-,62+/m1/s1
InChIKeyUIPKAULEVIFHCO-HQLLEASNSA-N
XLogP8.59
TPSA236.12 Ų
H-Bond Donors2
H-Bond Acceptors19
Rotatable Bonds17
Heavy Atoms87
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001375.23
LogP ≤ 58.59
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1019

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_C(246)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}

Analyze N-[(2S,3R,4S,6R)-2-[[(1S,3R,4R,8S,9R,12R,13S,14S,15R,16R)-5-[4-[3-cyclopentyloxy-N-[(3,5-dichloro-4-pyridinyl)methyl]-4-methoxyanilino]butyl]-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-9-iodo-3,8,12,14,16-pentamethyl-2,6,11-trioxo-7,10,17-trioxa-5-azatricyclo[14.2.1.04,8]nonadecan-15-yl]oxy]-3-hydroxy-6-methyloxan-4-yl]-N-methylmorpholine-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(2S,3R,4S,6R)-2-[[(1S,3R,4R,8S,9R,12R,13S,14S,15R,16R)-5-[4-[3-cyclopentyloxy-N-[(3,5-dichloro-4-pyridinyl)methyl]-4-methoxyanilino]butyl]-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-9-iodo-3,8,12,14,16-pentamethyl-2,6,11-trioxo-7,10,17-trioxa-5-azatricyclo[14.2.1.04,8]nonadecan-15-yl]oxy]-3-hydroxy-6-methyloxan-4-yl]-N-methylmorpholine-4-carboxamide?
The IUPAC name of N-[(2S,3R,4S,6R)-2-[[(1S,3R,4R,8S,9R,12R,13S,14S,15R,16R)-5-[4-[3-cyclopentyloxy-N-[(3,5-dichloro-4-pyridinyl)methyl]-4-methoxyanilino]butyl]-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-9-iodo-3,8,12,14,16-pentamethyl-2,6,11-trioxo-7,10,17-trioxa-5-azatricyclo[14.2.1.04,8]nonadecan-15-yl]oxy]-3-hydroxy-6-methyloxan-4-yl]-N-methylmorpholine-4-carboxamide (CID 89117843) is N-[(2S,3R,4S,6R)-2-[[(1S,3R,4R,8S,9R,12R,13S,14S,15R,16R)-5-[4-[3-cyclopentyloxy-N-[(3,5-dichloro-4-pyridinyl)methyl]-4-methoxyanilino]butyl]-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-9-iodo-3,8,12,14,16-pentamethyl-2,6,11-trioxo-7,10,17-trioxa-5-azatricyclo[14.2.1.04,8]nonadecan-15-yl]oxy]-3-hydroxy-6-methyloxan-4-yl]-N-methylmorpholine-4-carboxamide.
What is the SMILES notation for N-[(2S,3R,4S,6R)-2-[[(1S,3R,4R,8S,9R,12R,13S,14S,15R,16R)-5-[4-[3-cyclopentyloxy-N-[(3,5-dichloro-4-pyridinyl)methyl]-4-methoxyanilino]butyl]-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-9-iodo-3,8,12,14,16-pentamethyl-2,6,11-trioxo-7,10,17-trioxa-5-azatricyclo[14.2.1.04,8]nonadecan-15-yl]oxy]-3-hydroxy-6-methyloxan-4-yl]-N-methylmorpholine-4-carboxamide?
The canonical SMILES for N-[(2S,3R,4S,6R)-2-[[(1S,3R,4R,8S,9R,12R,13S,14S,15R,16R)-5-[4-[3-cyclopentyloxy-N-[(3,5-dichloro-4-pyridinyl)methyl]-4-methoxyanilino]butyl]-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-9-iodo-3,8,12,14,16-pentamethyl-2,6,11-trioxo-7,10,17-trioxa-5-azatricyclo[14.2.1.04,8]nonadecan-15-yl]oxy]-3-hydroxy-6-methyloxan-4-yl]-N-methylmorpholine-4-carboxamide is COc1ccc(N(CCCCN2C(=O)O[C@]3(C)[C@@H](I)OC(=O)[C@H](C)[C@@H](O[C@H]4C[C@@](C)(OC)[C@@H](O)[C@H](C)O4)[C@H](C)[C@@H](O[C@@H]4O[C@H](C)C[C@H](N(C)C(=O)N5CCOCC5)[C@H]4O)[C@@]4(C)C[C@@H](CO4)C(=O)[C@H](C)[C@@H]23)Cc2c(Cl)cncc2Cl)cc1OC1CCCC1.
What is the InChIKey of N-[(2S,3R,4S,6R)-2-[[(1S,3R,4R,8S,9R,12R,13S,14S,15R,16R)-5-[4-[3-cyclopentyloxy-N-[(3,5-dichloro-4-pyridinyl)methyl]-4-methoxyanilino]butyl]-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-9-iodo-3,8,12,14,16-pentamethyl-2,6,11-trioxo-7,10,17-trioxa-5-azatricyclo[14.2.1.04,8]nonadecan-15-yl]oxy]-3-hydroxy-6-methyloxan-4-yl]-N-methylmorpholine-4-carboxamide?
The InChIKey is UIPKAULEVIFHCO-HQLLEASNSA-N. The full InChI is InChI=1S/C62H90Cl2IN5O17/c1-34-26-45(67(9)58(75)68-22-24-79-25-23-68)50(72)56(81-34)85-54-36(3)51(84-48-29-60(6,78-11)53(73)38(5)82-48)37(4)55(74)86-57(65)62(8)52(35(2)49(71)39-28-61(54,7)80-33-39)70(59(76)87-62)21-15-14-20-69(32-42-43(63)30-66-31-44(42)64)40-18-19-46(77-10)47(27-40)83-41-16-12-13-17-41/h18-19,27,30-31,34-39,41,45,48,50-54,56-57,72-73H,12-17,20-26,28-29,32-33H2,1-11H3/t34-,35+,36+,37-,38+,39+,45+,48+,50-,51+,52-,53+,54-,56+,57+,60-,61-,62+/m1/s1.
What are the key properties of N-[(2S,3R,4S,6R)-2-[[(1S,3R,4R,8S,9R,12R,13S,14S,15R,16R)-5-[4-[3-cyclopentyloxy-N-[(3,5-dichloro-4-pyridinyl)methyl]-4-methoxyanilino]butyl]-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-9-iodo-3,8,12,14,16-pentamethyl-2,6,11-trioxo-7,10,17-trioxa-5-azatricyclo[14.2.1.04,8]nonadecan-15-yl]oxy]-3-hydroxy-6-methyloxan-4-yl]-N-methylmorpholine-4-carboxamide?
N-[(2S,3R,4S,6R)-2-[[(1S,3R,4R,8S,9R,12R,13S,14S,15R,16R)-5-[4-[3-cyclopentyloxy-N-[(3,5-dichloro-4-pyridinyl)methyl]-4-methoxyanilino]butyl]-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-9-iodo-3,8,12,14,16-pentamethyl-2,6,11-trioxo-7,10,17-trioxa-5-azatricyclo[14.2.1.04,8]nonadecan-15-yl]oxy]-3-hydroxy-6-methyloxan-4-yl]-N-methylmorpholine-4-carboxamide has a molecular weight of 1375.23 g/mol, XLogP of 8.59, 17 rotatable bonds, 2 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(2S,3R,4S,6R)-2-[[(1S,3R,4R,8S,9R,12R,13S,14S,15R,16R)-5-[4-[3-cyclopentyloxy-N-[(3,5-dichloro-4-pyridinyl)methyl]-4-methoxyanilino]butyl]-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-9-iodo-3,8,12,14,16-pentamethyl-2,6,11-trioxo-7,10,17-trioxa-5-azatricyclo[14.2.1.04,8]nonadecan-15-yl]oxy]-3-hydroxy-6-methyloxan-4-yl]-N-methylmorpholine-4-carboxamide is sourced from PubChem (CID 89117843), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).